FNY Investment Advisers’s Idexx Laboratories IDXX Stock Holding History

FNY Investment Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2	Closed	–	–	825
2018 Q3	$0	Buy	+2	New	+$485	﹤0.01%	1072

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FNY Investment Advisers's IDXX Position: Q4 2018 in Review

FNY Investment Advisers sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 2 shares.

FNY Investment Advisers first reported a position in IDXX in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 670 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

FNY Investment Advisers reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
FNY Investment Advisers sold 2 Idexx Laboratories shares in Q4 2018.
FNY Investment Advisers first reported a position in Idexx Laboratories in Q3 2018 and held it in 1 quarter.
FNY Investment Advisers's Idexx Laboratories position peaked at $0 in Q3 2018.
670 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on FNY Investment Advisers's 13F filing for Q4 2018, filed 22 Jan 2019.